MODERNA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.41 USD | -2.31% |
|
+21.58% | -0.41% |
| Jan. 24 | Health Care Up on Novo Nordisk Optimism -- Health Care Roundup | DJ |
| Jan. 24 | S&P 500 Posts Weekly Gain Amid Earnings Beats, Start of Trump Presidency | MT |
Chart calendar Moderna, Inc.
e91f2f869202765179fd89ea7763.OxLYzMsRXJI1jtfSY17CbfS7LuM79P638v2jhKQsM50.Q1jtnJ1wO8d-y4_jNTSEKbPsYM4LrYf4m6eUs_t-ffoIfqv-_igW_Xzi5w~633740effe27d01907b80a7d19088ef4
Upcoming events on Moderna, Inc.
Past events on Moderna, Inc.
| 2025-01-13 06:45 pm | JP Morgan Healthcare Conference |
| 2024-12-05 10:30 am | Piper Sandler Healthcare Conference |
| 2024-12-04 01:20 pm | Evercore ISI HealthCONx Conference |
| 2024-11-21 09:00 am | Jefferies London Healthcare Conference |
| 2024-11-13 06:30 pm | UBS Global Healthcare Conference |
| 2024-11-12 10:00 am | Guggenheim Securities Healthcare Innovation Conference |
| 2024-11-07 08:00 am | Q3 2024 Earnings Call |
| 2024-11-07 06:30 am | Q3 2024 Earnings Release |
| 2024-09-12 09:00 am | R&D Day |
| 2024-08-01 08:00 am | Q2 2024 Earnings Call |
| 2024-08-01 06:30 am | Q2 2024 Earnings Release |
| 2024-06-10 01:20 pm | Goldman Sachs Global Healthcare Conference |
| 2024-06-06 10:00 am | Jefferies Global Healthcare Conference |
| 2024-06-03 07:15 pm | American Society of Clinical Oncology Meeting |
| 2024-06-03 11:15 am | American Society of Clinical Oncology Meeting - Abstract: #LBA9512 |
| 2024-06-01 02:30 pm | American Society of Clinical Oncology Meeting - Abstract #TPS8116 |
| 2024-06-01 02:30 pm | American Society of Clinical Oncology Meeting - Abstract #TPS9616 |
| 2024-05-31 10:00 am | Bernstein Strategic Decisions Conference |
| 2024-05-13 | RBC Capital Markets Global Healthcare Conference |
| 2024-05-06 08:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 18 471 17 940 2.96% | 19 263 19 134 0.67% | 6 848 6 514 5.13% | 3 252 | 2 327 | 3 304 |
|
EBITDA Million USD | Released Forecast Spread | 13 528 12 626 7.14% | 9 768 10 056 -2.86% | -3 618 -4 681 22.71% | -3 615 | -3 316 | -2 539 |
|
EBIT Million USD | Released Forecast Spread | 13 296 12 562 5.84% | 9 420 9 956 -5.38% | -4 239 -4 868 12.91% | -3 888 | -3 749 | -2 922 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 13 285 12 585 5.56% | 9 575 10 119 -5.37% | -3 942 -4 505 12.49% | -3 516 | -3 462 | -2 586 |
|
Net income Million USD | Released Forecast Spread | 12 202 11 445 6.62% | 8 362 8 739 -4.31% | -4 714 -5 283 10.77% | -3 554 | -3 525 | -2 742 |
|
EPS USD | Released Forecast Spread | 28,3 26,9 5.17% | 20,1 21,3 -5.53% | -12,3 -13,5 8.92% | -9,31 | -9,04 | -7,04 |
| Announcement Date | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 862 1 120 66.24% | 344 306 12.58% | 1 831 1 382 32.49% | 2 811 2 533 11% | 167 125 33.25% | 241 135 78.69% | 1 862 1 247 49.32% | 1 003 | 200 | 191 | 1 069 | 775 |
|
EBITDA Million USD | Released Forecast Spread | 208 -1 081 119.24% | -1 322 -1 351 2.15% | -18,0 -809 97.77% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -366 -658 44.42% | -1 867 -1 684 -10.88% | -2 012 -852 -136.15% | 6,00 -512 101.17% | -1 266 -1 412 10.36% | -1 363 -1 338 -1.83% | -70,0 -840 91.67% | -1 126 | -1 248 | -1 267 | -526 | -791 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -305 -572 46.72% | -1 749 -1 606 -8.9% | -1 958 -735 -166.48% | 70,0 -451 115.52% | -1 165 -1 338 12.93% | -1 279 -1 269 -0.82% | 21,0 -759 102.77% | -1 019 | -1 168 | -1 187 | -424 | -775 |
|
Net income Million USD | Released Forecast Spread | 79,0 -662 111.93% | -1 380 -1 587 13.06% | -3 630 -754 -381.44% | 217 -347 162.57% | -1 175 -1 387 15.29% | -1 279 -1 296 1.3% | 13,0 -780 101.67% | -1 054 | -1 135 | -1 150 | -539 | -821 |
|
EPS USD | Released Forecast Spread | 0,19 -1,74 110.9% | -3,62 -4,10 11.66% | -9,53 -1,98 -381.38% | 0,55 -0,98 156.29% | -3,07 -3,57 14.06% | -3,33 -3,35 0.65% | 0,03 -1,93 101.55% | -2,67 | -2,96 | -2,99 | -1,30 | -1,89 |
| Announcement Date | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | 02/05/24 | 01/08/24 | 07/11/24 | - | - | - | - | - |
| 2025-01-28 | LONZA GROUP AG: Q4 2024 Earnings Release |
| 2025-02-05 06:30 am | BIO-TECHNE CORPORATION: Q2 2025 Earnings Release |
| 2025-02-05 04:05 pm | QIAGEN N.V.: Q4 2024 Earnings Release |
| 2025-02-05 | REPLIMUNE GROUP, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-06 07:00 am | IQVIA HOLDINGS INC.: Q4 2024 Earnings Release |
| 2025-02-09 | MEDPACE HOLDINGS, INC.: Q4 2024 Earnings Release |
| 2025-02-10 | AZENTA, INC.: Q1 2025 Earnings Release (Projected) |
| 2025-02-11 | IMMUNOVANT, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-12 04:01 pm | GALAPAGOS NV: Q4 2024 Earnings Release |
Past sector events for Moderna, Inc.
| 2025-01-23 04:30 am | SYNGENE INTERNATIONAL LIMITED: Q3 2025 Earnings Release |
| 2025-01-15 02:00 am | GENUS PLC: Q2 2025 Sales and Revenue Release - Trading Update |
| 2025-01-10 12:34 am | POLARIS GROUP: December 2024 Sales and Revenue Release |
| 2024-12-09 03:53 am | POLARIS GROUP: November 2024 Sales and Revenue Release |
| 2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
| 2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
| 2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
| 2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
| 2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRNA Stock
- Calendar Moderna, Inc.